Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (140)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
734
Price
$535.71
Total Value
$393.21K
Shares Held After
331,627
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
167
Price
$534.30
Total Value
$89.23K
Shares Held After
332,361
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
215
Price
$533.14
Total Value
$114.63K
Shares Held After
332,528
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$531.94
Total Value
$170.22K
Shares Held After
332,743
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$530.13
Total Value
$127.23K
Shares Held After
333,063
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$528.72
Total Value
$190.34K
Shares Held After
333,303
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$527.90
Total Value
$147.81K
Shares Held After
333,663
% of Holdings
0.1%
Artiva Biotherapeutics, Inc. (ARTV)
Aslan Fred — Director
Shares
23,463
Price
$7.20
Total Value
$168.88K
Shares Held After
1,519,606
% of Holdings
1.5%
MeiraGTx Holdings plc (MGTX)
Naylor Stuart — CHIEF SCI OFCR, OPHTHALMOLOGY
Shares
27,659
Price
$10.64
Total Value
$294.29K
Shares Held After
613,187
% of Holdings
4.3%
Eton Pharmaceuticals, Inc. (ETON)
Krempa David — Chief Business Officer
Shares
4,166
Price
$55.07
Total Value
$229.41K
Shares Held After
43,381
% of Holdings
8.8%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
21,000
Price
$96.81
Total Value
$2.03M
Shares Held After
87,209
% of Holdings
19.4%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research&Development
Shares
3,500
Price
$61.38
Total Value
$214.83K
Shares Held After
153,902
% of Holdings
2.2%
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
272
Price
$13.61
Total Value
$3.70K
Shares Held After
709,153
% of Holdings
0.0%
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
58,061
Price
$12.92
Total Value
$750.24K
Shares Held After
709,425
% of Holdings
7.6%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,638
Price
$64.03
Total Value
$104.88K
Shares Held After
105,272
% of Holdings
1.5%
Ginkgo Bioworks Holdings, Inc. (DNA)
Coen Steven P. — Chief Financial Officer
Shares
2,403
Price
$15.00
Total Value
$36.05K
Shares Held After
49,448
% of Holdings
4.6%
Acrivon Therapeutics, Inc. (ACRV)
Miller Mary — Chief Legal Officer
Shares
294
Price
$1.99
Total Value
$585.06
Shares Held After
81,715
% of Holdings
0.4%
Vaxcyte, Inc. (PCVX)
Cowan Elvia — SVP, Finance&CAO
Shares
19,000
Price
$86.74
Total Value
$1.65M
Shares Held After
27,860
% of Holdings
40.5%
Vaxcyte, Inc. (PCVX)
Wassil Jim — EVP, Chief Scientific Ofc, COO
Shares
18,000
Price
$86.74
Total Value
$1.56M
Shares Held After
145,435
% of Holdings
11.0%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
235,477
Price
$27.13
Total Value
$6.39M
Shares Held After
0
% of Holdings
100.0%
Amylyx Pharmaceuticals, Inc. (AMLX)
MILNE GEORGE M JR — Director
Shares
30,000
Price
$27.70
Total Value
$830.90K
Shares Held After
782,881
% of Holdings
3.7%
ImmunityBio, Inc. (IBRX)
Simon Barry J. — Director
Shares
25,000
Price
$10.75
Total Value
$268.76K
Shares Held After
2,777,788
% of Holdings
0.9%
BICYCLE THERAPEUTICS PLC (BCYC)
Lee Kevin — Director
Shares
1,638
Price
$3.57
Total Value
$5.85K
Shares Held After
595,866
% of Holdings
0.3%
BICYCLE THERAPEUTICS PLC (BCYC)
Skynner Michael — CHIEF SCIENTIFIC OFFICER
Shares
503
Price
$3.57
Total Value
$1.80K
Shares Held After
154,726
% of Holdings
0.3%
BICYCLE THERAPEUTICS PLC (BCYC)
Perry Jennifer Scott — Chief Operating Officer
Shares
326
Price
$3.78
Total Value
$1.23K
Shares Held After
89,552
% of Holdings
0.4%
BICYCLE THERAPEUTICS PLC (BCYC)
Perry Jennifer Scott — Chief Operating Officer
Shares
80
Price
$3.56
Total Value
$284.80
Shares Held After
89,878
% of Holdings
0.1%
BICYCLE THERAPEUTICS PLC (BCYC)
Hannay Michael Charles Ferguson — CHIEF PROD&SUPPLY CHAIN OFF
Shares
242
Price
$3.57
Total Value
$863.94
Shares Held After
92,561
% of Holdings
0.3%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
72,000
Price
$97.23
Total Value
$7.00M
Shares Held After
108,209
% of Holdings
40.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$546.63
Total Value
$196.79K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
920
Price
$545.69
Total Value
$502.04K
Shares Held After
324,803
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,260
Price
$544.59
Total Value
$686.19K
Shares Held After
325,723
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
783
Price
$543.54
Total Value
$425.59K
Shares Held After
326,983
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
918
Price
$542.56
Total Value
$498.07K
Shares Held After
327,766
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,239
Price
$541.66
Total Value
$671.12K
Shares Held After
328,684
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,028
Price
$540.50
Total Value
$555.63K
Shares Held After
329,923
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
931
Price
$539.50
Total Value
$502.28K
Shares Held After
330,951
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
655
Price
$538.62
Total Value
$352.80K
Shares Held After
331,882
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
905
Price
$537.43
Total Value
$486.37K
Shares Held After
332,537
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
501
Price
$536.26
Total Value
$268.67K
Shares Held After
333,442
% of Holdings
0.2%
BICYCLE THERAPEUTICS PLC (BCYC)
Thompson Travis Alvin — Chief Financial Officer
Shares
79
Price
$3.57
Total Value
$282.03
Shares Held After
64,449
% of Holdings
0.1%
Artiva Biotherapeutics, Inc. (ARTV)
Aslan Fred — Director
Shares
61,696
Price
$6.84
Total Value
$421.83K
Shares Held After
1,543,069
% of Holdings
3.8%
Artiva Biotherapeutics, Inc. (ARTV)
Banerjee Subhashis — Chief Medical Officer
Shares
1,099
Price
$6.84
Total Value
$7.51K
Shares Held After
169,848
% of Holdings
0.6%
Artiva Biotherapeutics, Inc. (ARTV)
Horan Christopher — Chief Tech Operations Officer
Shares
10,340
Price
$6.84
Total Value
$70.70K
Shares Held After
312,744
% of Holdings
3.2%
Artiva Biotherapeutics, Inc. (ARTV)
Bush Jennifer — COO, CLO, Compliance Officer
Shares
8,370
Price
$6.84
Total Value
$57.23K
Shares Held After
366,159
% of Holdings
2.2%
Monte Rosa Therapeutics, Inc. (GLUE)
Bowen Matthew — Principal Accounting Officer
Shares
13
Price
$10.56
Total Value
$137.28
Shares Held After
25,891
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
5,182
Price
$29.67
Total Value
$153.75K
Shares Held After
377,802
% of Holdings
1.4%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
6,699
Price
$28.82
Total Value
$193.07K
Shares Held After
382,984
% of Holdings
1.7%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
1,694
Price
$2.06
Total Value
$3.49K
Shares Held After
2,858,657
% of Holdings
0.1%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
18,182
Price
$1.33
Total Value
$24.18K
Shares Held After
935,021
% of Holdings
1.9%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research&Investments
Shares
4,126
Price
$57.10
Total Value
$235.59K
Shares Held After
0
% of Holdings
100.0%
Showing 1–50 of 140 transactions (page 1 of 3)